Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Fleurence

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|November 7, 2006
Cost-effectiveness of biologic agents for treatment of autoimmune disorders: structured review of the literatureRachael Fleurence, Eldon Spackman
Journal of the American Medical Informatics Association : JAMIA|May 14, 2014
Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research, Sarah E Daugherty, Sarita Wahba, et al.
Pharmacoeconomics|April 21, 2010
Economic burden of multiple sclerosis: a systematic review of the literatureHuseyin Naci, Rachael Fleurence, Julie Birt, et al.
Journal of Medical Economics|January 6, 2010
The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literatureHuseyin Naci, Rachael Fleurence, Julie Birt, et al.
Health Affairs (Project Hope)|October 11, 2012
Reviewing hypothetical migraine studies using funding criteria from the Patient-Centered Outcomes Research InstituteJoe V Selby, Rachael Fleurence, Michael Lauer, et al.
European Journal of Preventive Cardiology|March 27, 2013
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trialsHuseyin Naci, Jasper J Brugts, Rachael Fleurence, et al.
Clinical Therapeutics|March 1, 2011
Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspectiveFeng Pan, Siyang Peng, Rachael Fleurence, et al.
European Journal of Preventive Cardiology|March 1, 2013
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trialsHuseyin Naci, Jasper J Brugts, Rachael Fleurence, et al.
Health Affairs (Project Hope)|February 6, 2013
How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agendaRachael Fleurence, Joe V Selby, Kara Odom-Walker, et al.
Psychopharmacology Bulletin|September 16, 2009
A systematic review of augmentation strategies for patients with major depressive disorderRachael Fleurence, Rebecca Williamson, Yonghua Jing, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|November 7, 2006
Cost-effectiveness of biologic agents for treatment of autoimmune disorders: structured review of the literatureRachael Fleurence, Eldon Spackman
Journal of the American Medical Informatics Association : JAMIA|May 14, 2014
Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research, Sarah E Daugherty, Sarita Wahba, et al.
Pharmacoeconomics|April 21, 2010
Economic burden of multiple sclerosis: a systematic review of the literatureHuseyin Naci, Rachael Fleurence, Julie Birt, et al.
Journal of Medical Economics|January 6, 2010
The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literatureHuseyin Naci, Rachael Fleurence, Julie Birt, et al.
Health Affairs (Project Hope)|October 11, 2012
Reviewing hypothetical migraine studies using funding criteria from the Patient-Centered Outcomes Research InstituteJoe V Selby, Rachael Fleurence, Michael Lauer, et al.
European Journal of Preventive Cardiology|March 27, 2013
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trialsHuseyin Naci, Jasper J Brugts, Rachael Fleurence, et al.
Clinical Therapeutics|March 1, 2011
Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspectiveFeng Pan, Siyang Peng, Rachael Fleurence, et al.
European Journal of Preventive Cardiology|March 1, 2013
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trialsHuseyin Naci, Jasper J Brugts, Rachael Fleurence, et al.
Health Affairs (Project Hope)|February 6, 2013
How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agendaRachael Fleurence, Joe V Selby, Kara Odom-Walker, et al.
Psychopharmacology Bulletin|September 16, 2009
A systematic review of augmentation strategies for patients with major depressive disorderRachael Fleurence, Rebecca Williamson, Yonghua Jing, et al.
Pageof 2